BRCA1 and neoplasm: Besides age at diagnosis, none of the clinicopathological variables tested in univariate analysis (FIGO stage, residual tumor, lymph node status, neoadjuvant chemotherapy and distant metastasis) correlated with BRCA1 promoter hypermethylation (Table 2).